
Our CNS disease models are developed under stringent quality control based on GLP principles, ensuring reproducibility and reliability in your research studies.
With years of expertise in preclinical research, our team understands the nuances of CNS disease models, enabling tailored solutions that meet your specific requirements.
We cater to different project scales with flexible Minimum Order Quantities (MOQ), allowing you to efficiently manage your research budget without compromising quality.
Our dedicated team offers extensive support during the research process, ensuring that you receive the necessary insights and assistance for your CNS research projects.





Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china